NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
Key findings of IMPROVE-IT trial and their possible significance for clinical practice are discussed.
Saved in:
| Main Author: | S. Yu. Martsevich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01) -
COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01) -
Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01) -
Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it?
by: N. O. Vasyukova, et al.
Published: (2019-07-01) -
Comparison of rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic cardiovascular disease and type 2 diabetes
by: Hyo-In Choi, et al.
Published: (2025-05-01)